Connect with us

Press Release

China Medical System (867.HK) is Included in the S&P Global Sustainability Yearbook 2025

Published

on

SHENZHEN, CHINAIn February 11th 2025, with a Corporate Sustainability Assessment (CSA) score of 61, surpassing 93% of global peers, China Medical System Holdings Limited (“CMS” or the “Group”) has been included in the S&P Global Sustainability Yearbook 2025 (the “Yearbook 2025”). This marks the Group’s first inclusion in the global edition of S&P Global Sustainability Yearbook (the “Yearbook”), following the S&P Global Sustainability Yearbook (China Edition) inclusion for consecutive two years.

Since its launch in 2008, the Yearbook’s professionalism and authority have been highly recognized by global ESG investors and other stakeholders. The Yearbook aims to identify outstanding companies in sustainable development from each industry. 7,690 companies across 62 industries were assessed, while only 780 stood out and were included in the Yearbook 2025. The inclusion in the Yearbook 2025 represents a high recognition of sustainable development practices of CMS.

CMS has been actively responding to the United Nations Sustainable Development Goals (SDGs) for years, by integrating ESG governance into its corporate strategy and formulating an ESG strategy covering various dimensions in operation. The Group continues to invest in innovation to enhance the accessibility of advanced diagnostic and treatment technologies, and actively take its social responsibilities to create greater value at the business, industry, and societal levels. The Group’s sustainability performance has also been recognized by several authoritative ESG rating institutions. The Group’s MSCI ESG rating has been maintained at “AA”; the Hong Kong Quality Assurance Agency (HKQAA) sustainability rating is in the top 10% of the industry; and the Sino-Securities Index ESG rating is “AA”.

In the future, with its ESG vision of “becoming a world-leading sustainable pharmaceutical enterprise”, CMS will strengthen its practices in corporate governance, social contributions, and environmental protection, working together with all stakeholders to promote sustainable development and contribute to the realization of a more habitable planet.

About CMS

CMS is a platform company linking pharmaceutical innovation and commercialization with strong product lifecycle management capability, dedicated to providing competitive products and services to meet unmet medical needs.

 

CMS focuses on the global first-in-class (FIC) and best-in-class (BIC) innovative products, and efficiently promotes the clinical research, development and commercialization of innovative products, enabling the continuous transformation of scientific research into clinical practices to benefit patients.

 

CMS deeply engages in several specialty therapeutic fields, and has developed proven commercialization capabilities, extensive networks and expert resources, resulting in leading academic and market positions for its major marketed products. CMS continues to promote the in-depth development of its advantageous specialty fields and expand business boundaries. While strengthening the competitiveness of the cardio-cerebrovascular/gastroenterology business, CMS independently operates its dermatology and medical aesthetics business, and ophthalmology business, aiming to gain leading positions in specialty therapeutic fields, whilst enhancing the scale and efficiency. At the same time, CMS has expanded its business territory to the Southeast Asian market, striving to become a “bridgehead” for global pharmaceutical companies to enter the Southeast Asian market, further escorting the sustainable and healthy development of the Group.

 

CMS Disclaimer and Forward-Looking Statements

This press release is not intended to promote any products to you and is not for advertising purposes. This press release does not recommend any drugs, medical devices and/or indications. If you want to know more about the diagnosis and treatment of specific diseases, please follow the opinions or guidance of your doctor or other medical and health professionals. Any treatment-related decisions made by healthcare professionals should be based on the patient’s specific circumstances and in accordance with the drug package insert.

 

This press release which has been prepared by CMS does not constitute any offer or invitation to purchase or subscribe for any securities, and shall not form the basis for or be relied on in connection with any contract or binding commitment whatsoever. This press release has been prepared by CMS based on information and data which it considers reliable, but CMS makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this press release. Certain matters discussed in this press release may contain statements regarding the Group’s market opportunity and business prospects that are individually and collectively forward-looking statements. Such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and assumptions that are difficult to predict. Any forward-looking statements and projections made by third parties included in this press release are not adopted by the Group and the Company is not responsible for such third-party statements and projections.

 

Media Contact

Brand: China Medical System Holdings Ltd.

Contact: CMS Investor Relations

Email: ir@cms.net.cn

Website: https://web.cms.net.cn/en/home/

Source: China Medical System Holdings Ltd.

About Author

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

Press Release

The Two Leading CBD Companies on the Danish Market – Raworganics and Wetality – Setting the Standard for Quality, Transparency, and Consumer Trust

Published

on

Copenhagen – The Danish CBD market has experienced remarkable growth in recent years. Consumers’ increasing interest in natural health products and plant-based alternatives has paved the way for several serious players – yet two names stand out above the rest: Wetality and Raworganics.

Both companies are known for their uncompromising commitment to quality, documentation, and transparency. Still, there are clear differences in philosophy, production methods, and overall results – differences that make Wetality the number one player on the market today.

Wetality – Quality, Transparency, and Scientific Precision

Wetality is widely recognized as Denmark’s leading producer of CBD and other cannabinoid-based products. Their range includes everything from classic CBD oils to expertly designed formulations aimed at supporting both physical and mental balance.

At Wetality, quality is not a promise – it’s a process. Every drop of CBD oil results from carefully controlled cultivation, harvesting, and production. The hemp plants used are grown 100% organically in one of Europe’s most favorable climate regions for hemp. The selected seeds ensure plants rich in active cannabinoids, and the harvest is still carried out traditionally – with deep respect for nature, craftsmanship, and teamwork.

Once harvested, the hemp is processed in a GMP-certified facility (Good Manufacturing Practice), ensuring that every step meets pharmaceutical standards. This guarantees that consumers always receive a pure, safe, and well-documented product.

To further ensure transparency and reliability, each batch of Wetality products is tested by independent, European-accredited laboratories. The results are made public so customers can see exactly what they are purchasing – a practice that has earned Wetality a strong reputation for trustworthiness among both private consumers and professional therapists.

Yet Wetality’s approach goes beyond precision and control. Each product is expertly formulated, combining advanced cannabinoid science with premium natural ingredients. The goal is to create balanced products that work in harmony with the body’s own endocannabinoid system.

This blend of science, nature, and ethics has created a loyal customer base and outstanding satisfaction.

Customer Testimonial – Louise Granstrøm Aagaard, Trustpilot:
“I have tried several of Wetality’s oils, but No.07 Night is my lifesaver during times of overthinking and poor sleep. I also introduced it to my father, who after a cancer treatment struggled to sleep for hours each night. The first night with No.07 Night, he slept like a rock and hasn’t gone without it since.”

This testimonial is just one of many that show how Wetality products not only meet expectations – they truly make a difference in people’s lives.

Raworganics – A Strong Player Focused on Organic Values and Sustainability

Raworganics has in recent years established itself as one of the most visible players in the Danish CBD market. With roots in organic farming and sustainable production, the company has built a solid reputation centered on authenticity and environmental responsibility.

Their range of CBD oils, capsules, and cosmetic products is based on organically grown hemp from carefully selected European farms. The company places strong emphasis on eco-friendly production methods and minimizing the use of additives.

Raworganics is particularly known for its cold-pressed oils, which preserve the plant’s natural terpenes and full spectrum of cannabinoids. Many customers appreciate the clean taste and the company’s transparency regarding origin and production.

With a passion for sustainability and a mission to make CBD accessible to everyone, Raworganics has built a loyal customer base. The company maintains competitive pricing and appeals to consumers who value green ethics and simplicity.

Summary: Wetality Sets the Benchmark for CBD in Denmark

While both Wetality and Raworganics deliver high-quality, organic, and sustainable CBD products, it is clear that Wetality leads the way in terms of verified quality, innovation, and consumer safety.

Where Raworganics impresses with its down-to-earth and sustainable approach, Wetality takes it a step further – with GMP-certified production, third-party testing, and a strong foundation in both science and ethics. Their products represent a new standard of transparency and excellence in the CBD industry, where every detail – from seed to bottle – is carefully controlled.

Consumers respond with trust and loyalty, and testimonials like that of Louise Granstrøm Aagaard highlight what many already know:

Wetality is not just a CBD brand – it is a mark of quality.

About Author

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

Press Release

Jacksonvilles Trusted Weight Loss and Aesthetics Clinic

Published

on

Jacksonville, Florida, United States, 9th Oct 2025 – RSLV Aesthetics, a leading provider of non-invasive aesthetics and wellness treatments, has officially launched Physician Guided Weight Loss by RSLV, a new medically supervised division designed to help clients achieve sustainable results through science-based programs that integrate medical weight management with advanced body contouring technology.

Combining Medical Expertise and Aesthetic Innovation

Physician Guided Weight Loss by RSLV offers individualized programs overseen by licensed medical professionals who address the root causes of weight gain, including metabolic imbalance, hormonal factors, and inflammation. Each plan is carefully designed to promote safe, long-term results by pairing medical supervision with targeted interventions such as prescription-assisted options, peptide protocols, and structured nutritional guidance. The program also emphasizes accountability and consistent follow-up to ensure clients stay on track and achieve measurable, lasting progress.

The division’s science-based approach allows patients to benefit from personalized treatment strategies that are both clinically effective and easy to maintain. This integration of medical precision and personalized care sets RSLV apart from conventional weight loss clinics in Jacksonville, offering clients a physician-guided experience focused on long-term health rather than quick fixes.

Aesthetic Technology That Complements Medical Wellness

In addition to its new medical weight loss division, RSLV Aesthetics continues to lead the region in non-surgical skin tightening, body sculpting, and facial rejuvenation. The clinic’s RSLV Sculpting technology offers enhance lymphatic drainage, promote collagen production, and tighten skin without downtime. These treatments are ideal for clients who want to improve their physique and skin quality naturally, complementing the internal health benefits of the weight loss program.

By merging Physician Guided Weight Loss with RSLV Aesthetics Body Sculpting, clients can achieve full-spectrum transformation—reducing weight safely while simultaneously refining body tone, improving skin elasticity, and restoring overall confidence. The synergy between medical supervision and advanced aesthetic technology ensures that every patient receives results that are visible, balanced, and sustainable.

A Comprehensive Approach to Aesthetics & Weight Loss

This holistic philosophy reflects RSLV’s belief that wellness and aesthetics are deeply connected. The company’s multidisciplinary team of medical professionals and aesthetic specialists work collaboratively to create programs that restore energy, balance, and confidence, making RSLV one of Florida’s most trusted names in medical weight loss and aesthetics.

About RSLV Aesthetics

RSLV Aesthetics is a Florida-based medical aesthetics and wellness brand specializing in non-invasive body contouring, skin rejuvenation, and physician-guided weight loss programs. The company’s mission is to deliver safe, evidence-based treatments that combine medical science with advanced technology to help clients look and feel their best.

RSLV Aesthetics proudly serves clients throughout Jacksonville, St. Augustine, Orange Park, Fleming Island, and surrounding areas.

Media Contact:
RSLV Aesthetics
4110 Southpoint Blvd, Jacksonville, FL 32216
www.RSLVAesthetics.com

Media Contact

Organization: RSLV Aesthetics

Contact Person: Bob Warren

Website: https://rslvaesthetics.com/

Email:
Contact@vertexviral.com

Contact Number: +19042573723

Address:4110 Southpoint Blvd

City: Jacksonville

State: Florida

Country:United States

Release id:35077

The post Jacksonvilles Trusted Weight Loss and Aesthetics Clinic appeared first on King Newswire. This content is provided by a third-party source.. King Newswire makes no warranties or representations in connection with it. King Newswire is a press release distribution agency and does not endorse or verify the claims made in this release. If you have any complaints or copyright concerns related to this article, please contact the company listed in the ‘Media Contact’ section

file

About Author

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

Press Release

CodexField: Building the “Power Grid” for AI Resources — Enabling Free Flow of Data and Models

Published

on

Throughout the history of AI, humanity has been fixated on the progress of models. From GPT-3 to GPT-5, Claude-4 to Gemini-2.5, each new generation pushes the boundaries of scale and speed. Yet after years of development, it has become increasingly clear: stronger models alone have not automatically driven transformative breakthroughs at the industrial level.

In high-barrier domains such as drug discovery, industrial control, and traffic scheduling, the real challenges companies face are often not about model accuracy — but about the inability of data and models themselves to flow smoothly. They exist like isolated islands, locked behind platform APIs: contributors gain little or no reward, while users lack transparent ways to trace sources or settle payments.

In fact, despite the apparent prosperity of today’s AI industry, the underlying flow of resources still operates in a “manual era”:

  • To use datasets from research institutions or third-party models, companies must sign piles of contracts, undergo legal reviews, and manually reconcile payments — a painfully slow process.
  • Independent developers who contribute models or algorithms often see their work vanish once wrapped into APIs — stripped of identity and devoid of revenue feedback.

It’s like having power plants but no electric grid — the energy exists, yet there’s no efficient way to deliver it.

What AI truly needs is a public infrastructure that enables data, models, and compute power to move securely across organizations. CodexField was born to address precisely this bottleneck. It aims to build an open “power grid” for the AI world — breaking down the walls of closed platforms, allowing distributed resources to be authenticated, identifiable, measurable, and settleable — so they can finally flow safely and reliably to where they’re needed most.

The “Power Grid” Woven by CodexField

CodexField is a Web3-native asset infrastructure designed for the AI industry, aiming to enable data and model ownership, invocation, and value circulation. It treats models, prompts, algorithmic code, and their derivatives as reusable intelligent assets, realizing the principle of “model as an asset, invocation as billing” through unified packaging and authorization standards. The platform provides a closed-loop system covering storage, ownership verification, authorization, metering, and profit distribution. It is compatible with multi-chain ecosystems and mainstream decentralized storage networks, allowing developers and institutions to flexibly define access rules via smart contracts, achieve cross-institutional sharing, and enable automated settlement.

The core value of CodexField lies in re-assetizing resources once hidden behind APIs—granting data and models property identity and automatic revenue feedback. This lowers collaboration and compliance costs, builds a standardized pipeline for cross-domain sharing and compliant invocation, and lays an institutional foundation for the deep integration of AI and Web3.

Assetizing AI Content Elements: Data, Models, and Code

At its core, an AI model is underpinned by an ever-evolving stack of algorithmic code, while the datasets and prompts supporting its training and inference are equally essential “content.” In traditional Web2 environments, these resources are typically accessed via APIs or compressed packages. Users can send a request and receive a result—but remain unable to trace which models or data were used, who contributed them, or how value should be recorded in legal or financial terms.

This “use-and-forget” model has long stifled AI innovation:

  • Independent model creators struggle to receive ongoing rewards for their contributions.
  • Companies and research institutions lack transparent provenance and compliance proofs when using external resources, often finding themselves entangled in copyright and audit issues.
  • Cross-industry data sharing is hindered by lengthy negotiations and manual reconciliations, leaving many potential applications stuck at the conceptual stage.

CodexField begins by introducing the concept of “content assetization”, aiming to establish unified identities and circulation rules for these fragmented intelligent resources. The platform introduces a “Content Capsule” mechanism — encapsulating datasets, models, code, and even inference scripts into identifiable, callable digital objects. During the on-chain process, each capsule is bound to the creator’s DID identity, version lineage, and integrity hash — effectively generating a proof of ownership that permanently records origin and integrity on the blockchain ledger.

To prevent these assets from becoming isolated again, CodexField further builds an open indexing protocol and a content evaluation system on top of the capsules:

  • The indexing protocol functions like a library catalog, creating an open directory for all on-chain capsules, allowing enterprises, research institutions, and developers to easily discover the resources they need.
  • The evaluation system ranks resources based on metrics such as invocation success rate, latency, compliance audits, and user ratings, ensuring that high-quality and reliable resources gain greater visibility.

This “index + rating” mechanism not only lowers the threshold for developers to access AI resources but also ensures that all on-chain data and models can be invoked globally under a unified standard. For example, a biopharmaceutical company seeking a third-party molecular structure recognition model no longer needs to spend weeks searching or signing paper contracts. Without risking data leakage, it can directly query the target capsule from the index layer, review its ratings and performance metrics, and invoke it according to on-chain authorization rules.

Through this mechanism, CodexField completes a full loop — from ownership verification to discoverability. It brings together distributed intelligent resources from platforms, laboratories, and individuals into a unified framework that is identifiable, searchable, verifiable, and tradable. This institutionalizes the foundation for automated authorization, metering, and revenue feedback. As a result, CodexField not only enhances industry-wide collaboration efficiency but also ensures that long-overlooked creators and data providers can truly share in the economic value generated by intelligent productivity.

Institutional Foundation

After AI content is assetized, CodexField further establishes an executable rule system for these assets—transforming the authorization terms, metering methods, and revenue-sharing logic once written in contracts into on-chain code and industry standards. Resource providers can use a license description language to define authorization duration, invocation frequency, applicable scenarios, and revocation conditions, generating corresponding capability credentials. In this way, traditional license agreements are abstracted into a set of programmable, callable, and self-executing rules.

When an asset is invoked, the system automatically generates a usage receipt, using MU (Metered Unit) as a unified measurement standard—essentially installing a “meter” for data and models. This ensures consistent metering across cloud environments, edge nodes, and trusted computing frameworks, making every invocation traceable. The platform’s built-in royalty graph automatically identifies all participants along the invocation path—data providers, model developers, and compute nodes—and distributes revenue through on-chain settlement routing, giving AI usage its first truly executable industry standard.

By contrast, most AI collaborations today still rely on paper contracts and trust-based mechanisms. For example, if a company wants to use medical imaging data from a research institute or invoke a third-party model, it must first sign contracts, undergo legal reviews, and reconcile transactions manually—a slow, opaque process that cannot support the rapid iteration AI development demands. As a result, vast amounts of data remain locked in silos, unable to circulate efficiently.

CodexField’s mechanism breaks through this barrier. Developers can seamlessly invoke external resources without rebuilding backend billing systems. Creators receive immediate, auditable rewards each time their data or models are used. Enterprises and research institutions can complete multi-party authorization, invocation, and settlement within a single system—dramatically reducing compliance and financial costs.

Through this institutionalized circulation model, previously fragmented AI resources gain attributes akin to electricity—measurable, payable, and traceable. It greatly lowers the threshold for industry-wide collaboration and establishes a fair, transparent, and continuously value-accruing economic foundation for innovation.

Collaborative Network: Open and Governable

As a Web3-oriented AI infrastructure, CodexField itself is a collaboratively built and jointly governed resource network comprising three core participant groups:

  • Data contributors provide the core data and knowledge resources required for model operation. These include standardized medical imaging, financial transaction records, remote sensing and climate data, as well as high-value corpora such as legal, medical, and scientific literature. They also encompass pre-trained models and feature extraction algorithms developed by independent developers or research teams—all of which can be directly accessed through Content Capsules.
  • Resource contributors act as the network’s power engine, supplying computation and hardware support for inference, storage, and cross-regional transmission. This includes GPU clusters, low-latency edge nodes, and trusted execution environments (TEEs) for sensitive sectors such as healthcare and finance—ensuring stability and security under high concurrency.
  • Application developers and institutions can seamlessly access global capsule-based resources through CodexField’s standardized interfaces, without the need to build their own backend systems. This enables scenarios such as intelligent customer service, content generation, industrial simulation, and precision medicine. Research institutions can also securely access cross-departmental or cross-organizational data and models within the same network, reducing compliance and transaction costs. Moreover, CodexField provides AI platforms and SaaS providers with underlying mechanisms for authorization and revenue distribution, transforming closed API ecosystems into open, verifiable, and profit-sharing resource markets.

To maintain network stability and prevent resource fragmentation, CodexField introduces a PoA (Proof of Access) consensus mechanism, using node availability and service quality as key assessment criteria. Nodes must maintain high uptime and respond quickly to requests. The system dynamically scores nodes based on access success rate, latency, and historical reliability. High-quality nodes receive higher revenue shares, while underperforming ones are marginalized or eliminated.

PoA endows this “power grid” with two defining characteristics:

  1. Open yet governable – Any compliant individual or institution can join as a node, but rewards are tied to contribution, preventing uncontrolled participation.
  2. Economically driven stability – By linking incentives to service quality, the network ensures continuous investment in bandwidth, computing power, and redundancy, providing a highly available, low-latency foundation for large-scale AI operations.

Under this architecture, CodexField functions as a public pipeline co-built by multiple participants. Data and models can be shared across organizations while preserving traceability and revenue sharing for contributors. The market-driven competition among resource providers enhances overall efficiency and elasticity. Developers can directly access high-quality global assets without building complex infrastructure.

This collaborative model liberates the AI industry from dependence on single cloud providers or centralized platforms, instead establishing an open, compliant, and sustainable resource network. It lays a solid institutional foundation for healthy governance and long-term incentives across the entire ecosystem.

As a key representative of the Web3 ecosystem, CodexField is pioneering the on-chain ownership and institutionalized circulation of data, models, and compute power—laying the groundwork for the emergence of an “AI Public Power Grid.” It is not only an early implementer but also a catalyst at a pivotal turning point in AI’s evolution. By enabling intelligent productivity to flow as safely and reliably as electricity, CodexField provides a trustworthy and reusable foundation for the coming decade—where AI will move from isolated pilots to systemic interconnection and large-scale democratization.

About CodexField

CodexField is a next-generation Web3 platform for on-chain content assetization. It transforms code, AI models, AIGC outputs, and knowledge into tradable, revenue-generating digital assets. By building full-stack infrastructure for ownership verification, permission control, and content financialization, CodexField is redefining how digital intelligence is created, shared, and monetized on-chain.

Website: codexfield.com
Twitter/X: x.com/CodexField
Telegram: t.me/Codexfield_Official
Telegram Ann: t.me/codexfieldannounce
Youtube: youtube.com/@CodexFieldOfficial

About Author

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

LATEST POST